Rank | Gene Set | Z-score |
---|---|---|
1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.98678226 |
2 | synaptic vesicle maturation (GO:0016188) | 5.59121138 |
3 | locomotory exploration behavior (GO:0035641) | 5.58877904 |
4 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.50822777 |
5 | vocalization behavior (GO:0071625) | 5.48595524 |
6 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.41034686 |
7 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.18343456 |
8 | synaptic vesicle exocytosis (GO:0016079) | 5.10014841 |
9 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.98268082 |
10 | glutamate secretion (GO:0014047) | 4.85679279 |
11 | neuron cell-cell adhesion (GO:0007158) | 4.83593880 |
12 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.81633054 |
13 | amino acid import (GO:0043090) | 4.77507228 |
14 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.73611310 |
15 | protein localization to synapse (GO:0035418) | 4.66892592 |
16 | neuronal action potential propagation (GO:0019227) | 4.61096978 |
17 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.48458881 |
18 | exploration behavior (GO:0035640) | 4.46697560 |
19 | glutamate receptor signaling pathway (GO:0007215) | 4.45052253 |
20 | layer formation in cerebral cortex (GO:0021819) | 4.44866686 |
21 | neurotransmitter secretion (GO:0007269) | 4.41227801 |
22 | gamma-aminobutyric acid transport (GO:0015812) | 4.36457948 |
23 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.35033143 |
24 | potassium ion homeostasis (GO:0055075) | 4.30928811 |
25 | synaptic transmission, glutamatergic (GO:0035249) | 4.25125106 |
26 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 4.24810828 |
27 | regulation of synapse structural plasticity (GO:0051823) | 4.24498672 |
28 | regulation of synaptic vesicle transport (GO:1902803) | 4.23562935 |
29 | dendritic spine morphogenesis (GO:0060997) | 4.16251263 |
30 | potassium ion import (GO:0010107) | 4.16149626 |
31 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.15418860 |
32 | axon ensheathment in central nervous system (GO:0032291) | 4.12812720 |
33 | central nervous system myelination (GO:0022010) | 4.12812720 |
34 | neuron-neuron synaptic transmission (GO:0007270) | 4.06535988 |
35 | regulation of ARF protein signal transduction (GO:0032012) | 4.02191856 |
36 | cellular potassium ion homeostasis (GO:0030007) | 4.00645744 |
37 | long-term memory (GO:0007616) | 3.95937471 |
38 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.92821278 |
39 | transmission of nerve impulse (GO:0019226) | 3.84335295 |
40 | neuron recognition (GO:0008038) | 3.82668437 |
41 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.81550833 |
42 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.80742642 |
43 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.79120846 |
44 | proline transport (GO:0015824) | 3.78870250 |
45 | cellular sodium ion homeostasis (GO:0006883) | 3.72276397 |
46 | positive regulation of membrane potential (GO:0045838) | 3.69957835 |
47 | neurotransmitter transport (GO:0006836) | 3.68947498 |
48 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.65491975 |
49 | sodium ion export (GO:0071436) | 3.63696421 |
50 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.63293923 |
51 | regulation of postsynaptic membrane potential (GO:0060078) | 3.62606959 |
52 | regulation of synapse maturation (GO:0090128) | 3.61553193 |
53 | prepulse inhibition (GO:0060134) | 3.53099043 |
54 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.52760234 |
55 | neuromuscular process controlling balance (GO:0050885) | 3.50639566 |
56 | axonal fasciculation (GO:0007413) | 3.49516428 |
57 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.48505312 |
58 | regulation of synaptic plasticity (GO:0048167) | 3.48434622 |
59 | auditory behavior (GO:0031223) | 3.46838114 |
60 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.45526202 |
61 | regulation of neurotransmitter levels (GO:0001505) | 3.44834394 |
62 | positive regulation of synapse maturation (GO:0090129) | 3.44350001 |
63 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.43794296 |
64 | neurotransmitter uptake (GO:0001504) | 3.43617340 |
65 | activation of protein kinase A activity (GO:0034199) | 3.42796201 |
66 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.39621463 |
67 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.38979876 |
68 | acidic amino acid transport (GO:0015800) | 3.38906092 |
69 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.37738092 |
70 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.36322722 |
71 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.35287166 |
72 | postsynaptic membrane organization (GO:0001941) | 3.35069101 |
73 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.33718489 |
74 | synaptic vesicle endocytosis (GO:0048488) | 3.33665708 |
75 | mating behavior (GO:0007617) | 3.32283576 |
76 | * gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.30286209 |
77 | response to auditory stimulus (GO:0010996) | 3.30092776 |
78 | neuromuscular process controlling posture (GO:0050884) | 3.29759801 |
79 | regulation of vesicle fusion (GO:0031338) | 3.28257077 |
80 | long-term synaptic potentiation (GO:0060291) | 3.28050800 |
81 | dendrite morphogenesis (GO:0048813) | 3.27077150 |
82 | regulation of neurotransmitter secretion (GO:0046928) | 3.26785351 |
83 | glycine transport (GO:0015816) | 3.24669656 |
84 | neuronal ion channel clustering (GO:0045161) | 3.23659302 |
85 | cerebellar Purkinje cell layer development (GO:0021680) | 3.22200456 |
86 | cell differentiation in hindbrain (GO:0021533) | 3.17721056 |
87 | membrane depolarization (GO:0051899) | 3.17687378 |
88 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.14970704 |
89 | membrane depolarization during action potential (GO:0086010) | 3.14359411 |
90 | positive regulation of dendritic spine development (GO:0060999) | 3.13012312 |
91 | synapse assembly (GO:0007416) | 3.12798692 |
92 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.11874521 |
93 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.11543397 |
94 | presynaptic membrane assembly (GO:0097105) | 3.11469497 |
95 | membrane hyperpolarization (GO:0060081) | 3.10928341 |
96 | learning (GO:0007612) | 3.10809137 |
97 | regulation of dendritic spine development (GO:0060998) | 3.10749539 |
98 | response to histamine (GO:0034776) | 3.10296212 |
99 | cerebellar granule cell differentiation (GO:0021707) | 3.08399950 |
100 | regulation of neurotransmitter transport (GO:0051588) | 3.07259030 |
101 | cell communication involved in cardiac conduction (GO:0086065) | 3.04174517 |
102 | behavioral fear response (GO:0001662) | 3.03870117 |
103 | behavioral defense response (GO:0002209) | 3.03870117 |
104 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.02489190 |
105 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.02331860 |
106 | cell communication by electrical coupling (GO:0010644) | 3.02066137 |
107 | adult walking behavior (GO:0007628) | 3.01497440 |
108 | vesicle transport along microtubule (GO:0047496) | 3.00826895 |
109 | establishment of mitochondrion localization (GO:0051654) | 3.00384308 |
110 | presynaptic membrane organization (GO:0097090) | 2.99661084 |
111 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.99346269 |
112 | L-amino acid import (GO:0043092) | 2.98773256 |
113 | neuromuscular process (GO:0050905) | 2.98242107 |
114 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.98108206 |
115 | positive regulation of neurotransmitter transport (GO:0051590) | 2.98047235 |
116 | social behavior (GO:0035176) | 2.97592113 |
117 | intraspecies interaction between organisms (GO:0051703) | 2.97592113 |
118 | innervation (GO:0060384) | 2.96706171 |
119 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.95188073 |
120 | regulation of synaptic transmission (GO:0050804) | 2.94726895 |
121 | dendritic spine organization (GO:0097061) | 2.94039427 |
122 | L-glutamate transport (GO:0015813) | 2.93673991 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.12307458 |
2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.38385940 |
3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.15497276 |
4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.12984455 |
5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.12759888 |
6 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.77770449 |
7 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.77770449 |
8 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.69935889 |
9 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.67397525 |
10 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.66061869 |
11 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.63215329 |
12 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.57926506 |
13 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.56799716 |
14 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.54612509 |
15 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.54420533 |
16 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.53084607 |
17 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.53065289 |
18 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.51594867 |
19 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.31144047 |
20 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.29372401 |
21 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.28324532 |
22 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.20759334 |
23 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.16613056 |
24 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.06650897 |
25 | * IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.00872566 |
26 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.97139245 |
27 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.90834739 |
28 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.88802452 |
29 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.82875641 |
30 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.82864807 |
31 | * NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.78665091 |
32 | * MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.76964279 |
33 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.73897133 |
34 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.72540352 |
35 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.61520843 |
36 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.60882274 |
37 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.58893592 |
38 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.57810686 |
39 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.56950042 |
40 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.43102336 |
41 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.41354837 |
42 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.41112838 |
43 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.38727565 |
44 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.36750490 |
45 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.35139217 |
46 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.33622146 |
47 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.30804180 |
48 | P300_19829295_ChIP-Seq_ESCs_Human | 1.29436112 |
49 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.27870842 |
50 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.27638954 |
51 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.26623958 |
52 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.25719328 |
53 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.24316063 |
54 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.23497024 |
55 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.23379578 |
56 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.20995659 |
57 | STAT3_23295773_ChIP-Seq_U87_Human | 1.20501368 |
58 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.20492066 |
59 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.20287764 |
60 | AR_19668381_ChIP-Seq_PC3_Human | 1.20120928 |
61 | AR_25329375_ChIP-Seq_VCAP_Human | 1.17966069 |
62 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.17186396 |
63 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.16983000 |
64 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.16717096 |
65 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.16688365 |
66 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.16339140 |
67 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.15825573 |
68 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.15662463 |
69 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.15625489 |
70 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.15594956 |
71 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.14975005 |
72 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.14400326 |
73 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.11760547 |
74 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.10725140 |
75 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.10717107 |
76 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.10464103 |
77 | KDM2B_26808549_Chip-Seq_K562_Human | 1.06664626 |
78 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.06384999 |
79 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.05888609 |
80 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.04681831 |
81 | TCF4_23295773_ChIP-Seq_U87_Human | 1.04201430 |
82 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.03798759 |
83 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.03607674 |
84 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.03589730 |
85 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.03116645 |
86 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.02568743 |
87 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.02008335 |
88 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.01448393 |
89 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.01327186 |
90 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.01225150 |
91 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.00996859 |
92 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.00937479 |
93 | TP53_16413492_ChIP-PET_HCT116_Human | 1.00534255 |
94 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.00141860 |
95 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.98699131 |
96 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.98470224 |
97 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.97559822 |
98 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.97077033 |
99 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.96680662 |
100 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.95999569 |
101 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95950113 |
102 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.93990116 |
103 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.93343225 |
104 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.92952606 |
105 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.92900573 |
106 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.92807386 |
107 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.91906159 |
108 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.91173763 |
109 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.90865851 |
110 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.90634337 |
111 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.90342213 |
112 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.89349867 |
113 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.89325004 |
114 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88958630 |
115 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.88556532 |
116 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.88509320 |
117 | * DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.87528338 |
118 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.86984164 |
119 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.86668482 |
120 | FUS_26573619_Chip-Seq_HEK293_Human | 0.86190863 |
121 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.85023988 |
122 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.85023988 |
123 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.84733874 |
124 | RXR_22108803_ChIP-Seq_LS180_Human | 0.83575268 |
125 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.82978954 |
126 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.82875672 |
127 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.79552587 |
128 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.77286017 |
129 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.76586660 |
130 | RUNX1_26923725_Chip-Seq_HPCs_Mouse | 0.76342820 |
131 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.75765328 |
132 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.75480986 |
133 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 0.74568076 |
134 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.74407742 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004859_abnormal_synaptic_plasticity | 6.39069112 |
2 | MP0003880_abnormal_central_pattern | 5.08839001 |
3 | * MP0003635_abnormal_synaptic_transmissio | 4.22033709 |
4 | MP0004270_analgesia | 3.73942885 |
5 | * MP0009745_abnormal_behavioral_response | 3.47317060 |
6 | * MP0002063_abnormal_learning/memory/cond | 3.30644797 |
7 | MP0009046_muscle_twitch | 3.26475362 |
8 | * MP0002064_seizures | 3.20633189 |
9 | MP0005423_abnormal_somatic_nervous | 3.10222581 |
10 | MP0001968_abnormal_touch/_nociception | 3.02222456 |
11 | MP0002822_catalepsy | 2.92216587 |
12 | * MP0002572_abnormal_emotion/affect_behav | 2.79794833 |
13 | MP0001486_abnormal_startle_reflex | 2.71010782 |
14 | * MP0002272_abnormal_nervous_system | 2.67266625 |
15 | * MP0002734_abnormal_mechanical_nocicepti | 2.48179029 |
16 | MP0002736_abnormal_nociception_after | 2.31015131 |
17 | MP0001440_abnormal_grooming_behavior | 2.27285567 |
18 | MP0002735_abnormal_chemical_nociception | 2.15019159 |
19 | * MP0001501_abnormal_sleep_pattern | 2.08298493 |
20 | MP0002067_abnormal_sensory_capabilities | 2.03626090 |
21 | * MP0002733_abnormal_thermal_nociception | 2.00779283 |
22 | MP0003329_amyloid_beta_deposits | 1.98265044 |
23 | MP0008569_lethality_at_weaning | 1.96854109 |
24 | * MP0001970_abnormal_pain_threshold | 1.95374236 |
25 | MP0000778_abnormal_nervous_system | 1.88857386 |
26 | MP0002184_abnormal_innervation | 1.86292532 |
27 | MP0004924_abnormal_behavior | 1.83435605 |
28 | MP0005386_behavior/neurological_phenoty | 1.83435605 |
29 | MP0006276_abnormal_autonomic_nervous | 1.81812589 |
30 | MP0002557_abnormal_social/conspecific_i | 1.79778398 |
31 | MP0004858_abnormal_nervous_system | 1.76320310 |
32 | MP0009780_abnormal_chondrocyte_physiolo | 1.72386415 |
33 | MP0002909_abnormal_adrenal_gland | 1.67550798 |
34 | MP0004811_abnormal_neuron_physiology | 1.67462259 |
35 | MP0004885_abnormal_endolymph | 1.66290751 |
36 | MP0000955_abnormal_spinal_cord | 1.61986013 |
37 | MP0001529_abnormal_vocalization | 1.58524154 |
38 | MP0005646_abnormal_pituitary_gland | 1.50704869 |
39 | * MP0002066_abnormal_motor_capabilities/c | 1.46533464 |
40 | * MP0002882_abnormal_neuron_morphology | 1.43627593 |
41 | MP0004142_abnormal_muscle_tone | 1.41674805 |
42 | MP0001905_abnormal_dopamine_level | 1.40920813 |
43 | MP0001984_abnormal_olfaction | 1.39159463 |
44 | MP0003633_abnormal_nervous_system | 1.37205944 |
45 | MP0003879_abnormal_hair_cell | 1.34590460 |
46 | MP0005645_abnormal_hypothalamus_physiol | 1.32395009 |
47 | MP0001502_abnormal_circadian_rhythm | 1.28949447 |
48 | MP0003787_abnormal_imprinting | 1.23520676 |
49 | MP0003122_maternal_imprinting | 1.19130191 |
50 | MP0003631_nervous_system_phenotype | 1.18551718 |
51 | MP0002152_abnormal_brain_morphology | 1.14735232 |
52 | MP0003123_paternal_imprinting | 1.14325355 |
53 | MP0004145_abnormal_muscle_electrophysio | 1.12061855 |
54 | MP0001188_hyperpigmentation | 1.11110413 |
55 | MP0004742_abnormal_vestibular_system | 1.09879498 |
56 | MP0003690_abnormal_glial_cell | 1.06485532 |
57 | MP0008872_abnormal_physiological_respon | 1.06430106 |
58 | MP0002229_neurodegeneration | 1.04449752 |
59 | MP0000751_myopathy | 0.99688229 |
60 | * MP0000920_abnormal_myelination | 0.98364316 |
61 | MP0003634_abnormal_glial_cell | 0.96852584 |
62 | MP0001177_atelectasis | 0.96431308 |
63 | MP0005409_darkened_coat_color | 0.96108182 |
64 | MP0003172_abnormal_lysosome_physiology | 0.95713022 |
65 | MP0002069_abnormal_eating/drinking_beha | 0.93199713 |
66 | MP0005551_abnormal_eye_electrophysiolog | 0.92899859 |
67 | MP0001986_abnormal_taste_sensitivity | 0.91849104 |
68 | MP0003632_abnormal_nervous_system | 0.91575596 |
69 | MP0001348_abnormal_lacrimal_gland | 0.87285369 |
70 | MP0003283_abnormal_digestive_organ | 0.86655055 |
71 | MP0000604_amyloidosis | 0.86262612 |
72 | MP0000013_abnormal_adipose_tissue | 0.85713135 |
73 | * MP0008874_decreased_physiological_sensi | 0.83912613 |
74 | MP0001963_abnormal_hearing_physiology | 0.83392545 |
75 | MP0004085_abnormal_heartbeat | 0.83374815 |
76 | MP0010386_abnormal_urinary_bladder | 0.81594923 |
77 | MP0000569_abnormal_digit_pigmentation | 0.80907154 |
78 | MP0003075_altered_response_to | 0.79760676 |
79 | MP0008961_abnormal_basal_metabolism | 0.78584579 |
80 | * MP0002752_abnormal_somatic_nervous | 0.77052149 |
81 | MP0000631_abnormal_neuroendocrine_gland | 0.76951779 |
82 | MP0001485_abnormal_pinna_reflex | 0.76901856 |
83 | * MP0005535_abnormal_body_temperature | 0.73488684 |
84 | MP0005499_abnormal_olfactory_system | 0.72962438 |
85 | MP0005394_taste/olfaction_phenotype | 0.72962438 |
86 | MP0000579_abnormal_nail_morphology | 0.72866172 |
87 | MP0004130_abnormal_muscle_cell | 0.71954136 |
88 | MP0003137_abnormal_impulse_conducting | 0.71019968 |
89 | MP0002090_abnormal_vision | 0.70581115 |
90 | MP0002249_abnormal_larynx_morphology | 0.70073927 |
91 | MP0005623_abnormal_meninges_morphology | 0.69709988 |
92 | MP0005167_abnormal_blood-brain_barrier | 0.66601856 |
93 | MP0001664_abnormal_digestion | 0.66180005 |
94 | MP0001299_abnormal_eye_distance/ | 0.65270864 |
95 | MP0002837_dystrophic_cardiac_calcinosis | 0.64026554 |
96 | MP0004215_abnormal_myocardial_fiber | 0.63516789 |
97 | MP0001346_abnormal_lacrimal_gland | 0.63048331 |
98 | MP0004484_altered_response_of | 0.62160384 |
99 | MP0000026_abnormal_inner_ear | 0.59840335 |
100 | MP0003861_abnormal_nervous_system | 0.59329190 |
101 | MP0001943_abnormal_respiration | 0.59251582 |
102 | MP0002653_abnormal_ependyma_morphology | 0.58492680 |
103 | * MP0010768_mortality/aging | 0.57868887 |
104 | MP0002638_abnormal_pupillary_reflex | 0.57682534 |
105 | MP0003938_abnormal_ear_development | 0.55949568 |
106 | MP0004147_increased_porphyrin_level | 0.55717920 |
107 | MP0004510_myositis | 0.55617970 |
108 | MP0004233_abnormal_muscle_weight | 0.54666526 |
109 | * MP0010769_abnormal_survival | 0.54194836 |
110 | MP0006072_abnormal_retinal_apoptosis | 0.53210691 |
111 | MP0000747_muscle_weakness | 0.53069258 |
112 | * MP0002082_postnatal_lethality | 0.52247336 |
113 | * MP0010770_preweaning_lethality | 0.52247336 |
114 | MP0003121_genomic_imprinting | 0.52238280 |
115 | MP0002133_abnormal_respiratory_system | 0.51125091 |
116 | MP0005388_respiratory_system_phenotype | 0.51125091 |
117 | MP0003183_abnormal_peptide_metabolism | 0.48620943 |
118 | * MP0003956_abnormal_body_size | 0.48250559 |
119 | MP0008877_abnormal_DNA_methylation | 0.48023954 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Focal motor seizures (HP:0011153) | 7.59677030 |
2 | Myokymia (HP:0002411) | 6.74836344 |
3 | Focal seizures (HP:0007359) | 5.79572496 |
4 | Visual hallucinations (HP:0002367) | 5.37366955 |
5 | Atonic seizures (HP:0010819) | 4.54640473 |
6 | Epileptic encephalopathy (HP:0200134) | 4.48217785 |
7 | Progressive cerebellar ataxia (HP:0002073) | 4.39905268 |
8 | Absence seizures (HP:0002121) | 4.19491536 |
9 | Febrile seizures (HP:0002373) | 4.15427195 |
10 | Action tremor (HP:0002345) | 4.07702169 |
11 | Supranuclear gaze palsy (HP:0000605) | 4.02221542 |
12 | Generalized tonic-clonic seizures (HP:0002069) | 3.88721524 |
13 | Dialeptic seizures (HP:0011146) | 3.82233336 |
14 | Broad-based gait (HP:0002136) | 3.71778796 |
15 | Ankle clonus (HP:0011448) | 3.42203492 |
16 | Dysdiadochokinesis (HP:0002075) | 3.36062872 |
17 | Poor eye contact (HP:0000817) | 3.34950997 |
18 | Gaze-evoked nystagmus (HP:0000640) | 3.33250125 |
19 | Neurofibrillary tangles (HP:0002185) | 3.30071404 |
20 | Dysmetria (HP:0001310) | 3.30009592 |
21 | Depression (HP:0000716) | 3.21041603 |
22 | Mutism (HP:0002300) | 3.19433461 |
23 | Cerebral inclusion bodies (HP:0100314) | 3.13924146 |
24 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.10689914 |
25 | Truncal ataxia (HP:0002078) | 3.07874796 |
26 | Impaired social interactions (HP:0000735) | 3.06371986 |
27 | Abnormal social behavior (HP:0012433) | 3.06371986 |
28 | Anxiety (HP:0000739) | 3.06078829 |
29 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.05598663 |
30 | Papilledema (HP:0001085) | 2.97560338 |
31 | Postural instability (HP:0002172) | 2.96236375 |
32 | Tetraplegia (HP:0002445) | 2.95610163 |
33 | Abnormal eating behavior (HP:0100738) | 2.92417342 |
34 | Sleep apnea (HP:0010535) | 2.90753883 |
35 | Hyperventilation (HP:0002883) | 2.89491140 |
36 | Hemiparesis (HP:0001269) | 2.88981828 |
37 | Scanning speech (HP:0002168) | 2.87040137 |
38 | Limb dystonia (HP:0002451) | 2.85662153 |
39 | Abnormality of binocular vision (HP:0011514) | 2.85653956 |
40 | Diplopia (HP:0000651) | 2.85653956 |
41 | Genetic anticipation (HP:0003743) | 2.80361354 |
42 | Progressive inability to walk (HP:0002505) | 2.77823081 |
43 | Intention tremor (HP:0002080) | 2.76118621 |
44 | Urinary urgency (HP:0000012) | 2.74086367 |
45 | Drooling (HP:0002307) | 2.73713599 |
46 | Excessive salivation (HP:0003781) | 2.73713599 |
47 | Amblyopia (HP:0000646) | 2.73527179 |
48 | Cerebral hypomyelination (HP:0006808) | 2.73089004 |
49 | Spastic gait (HP:0002064) | 2.71907251 |
50 | Abnormality of the corticospinal tract (HP:0002492) | 2.66308693 |
51 | Impaired smooth pursuit (HP:0007772) | 2.63978687 |
52 | Hemiplegia (HP:0002301) | 2.63112905 |
53 | Insidious onset (HP:0003587) | 2.52917458 |
54 | Termporal pattern (HP:0011008) | 2.52917458 |
55 | Torticollis (HP:0000473) | 2.50324675 |
56 | Abnormality of the lower motor neuron (HP:0002366) | 2.47022968 |
57 | Bradykinesia (HP:0002067) | 2.46598644 |
58 | Megalencephaly (HP:0001355) | 2.45577986 |
59 | Apathy (HP:0000741) | 2.42652746 |
60 | Stereotypic behavior (HP:0000733) | 2.42496428 |
61 | Status epilepticus (HP:0002133) | 2.37011198 |
62 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.34337172 |
63 | Focal dystonia (HP:0004373) | 2.28785844 |
64 | Fetal akinesia sequence (HP:0001989) | 2.28077245 |
65 | Epileptiform EEG discharges (HP:0011182) | 2.26813859 |
66 | Absent speech (HP:0001344) | 2.26796038 |
67 | Lower limb muscle weakness (HP:0007340) | 2.25763266 |
68 | Pheochromocytoma (HP:0002666) | 2.23715421 |
69 | Ventricular fibrillation (HP:0001663) | 2.22572500 |
70 | Amyotrophic lateral sclerosis (HP:0007354) | 2.19987881 |
71 | EEG with generalized epileptiform discharges (HP:0011198) | 2.18261200 |
72 | Generalized myoclonic seizures (HP:0002123) | 2.15726952 |
73 | Bronchomalacia (HP:0002780) | 2.14700889 |
74 | Diminished motivation (HP:0000745) | 2.13651756 |
75 | Neuronal loss in central nervous system (HP:0002529) | 2.13623140 |
76 | Split foot (HP:0001839) | 2.11040963 |
77 | Annular pancreas (HP:0001734) | 2.09889744 |
78 | Polyphagia (HP:0002591) | 2.09201246 |
79 | Dysmetric saccades (HP:0000641) | 2.06243566 |
80 | Hypsarrhythmia (HP:0002521) | 2.05954943 |
81 | Agitation (HP:0000713) | 2.04552496 |
82 | Craniofacial dystonia (HP:0012179) | 2.04548252 |
83 | Insomnia (HP:0100785) | 2.04442717 |
84 | Inability to walk (HP:0002540) | 2.03543177 |
85 | Lower limb asymmetry (HP:0100559) | 2.03318301 |
86 | Impaired vibratory sensation (HP:0002495) | 2.02381570 |
87 | Increased circulating renin level (HP:0000848) | 2.01341440 |
88 | Spastic tetraparesis (HP:0001285) | 2.00410902 |
89 | Pointed chin (HP:0000307) | 1.96894895 |
90 | Gait ataxia (HP:0002066) | 1.96282758 |
91 | Psychosis (HP:0000709) | 1.95884040 |
92 | Turricephaly (HP:0000262) | 1.94797179 |
93 | Peripheral hypomyelination (HP:0007182) | 1.94583660 |
94 | Spinal canal stenosis (HP:0003416) | 1.92663454 |
95 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.91420455 |
96 | Blue irides (HP:0000635) | 1.90929147 |
97 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.89175082 |
98 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.89175082 |
99 | Thickened helices (HP:0000391) | 1.89054518 |
100 | Lower limb amyotrophy (HP:0007210) | 1.88984753 |
101 | Clonus (HP:0002169) | 1.88575486 |
102 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.88348840 |
103 | Aplasia of the phalanges of the hand (HP:0009802) | 1.88348840 |
104 | Aplasia involving bones of the extremities (HP:0009825) | 1.88348840 |
105 | Rigidity (HP:0002063) | 1.88170239 |
106 | Incomplete penetrance (HP:0003829) | 1.87715658 |
107 | Rapidly progressive (HP:0003678) | 1.87660014 |
108 | Neuroendocrine neoplasm (HP:0100634) | 1.87413696 |
109 | Inappropriate behavior (HP:0000719) | 1.86345385 |
110 | Abnormality of saccadic eye movements (HP:0000570) | 1.85959779 |
111 | Obstructive sleep apnea (HP:0002870) | 1.85813963 |
112 | Abnormality of salivation (HP:0100755) | 1.85407541 |
113 | Choreoathetosis (HP:0001266) | 1.82291455 |
114 | Akinesia (HP:0002304) | 1.81849129 |
115 | Delusions (HP:0000746) | 1.78068772 |
116 | Memory impairment (HP:0002354) | 1.74875015 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EPHA4 | 4.50902228 |
2 | NTRK3 | 4.40148966 |
3 | MAP3K9 | 3.87669873 |
4 | MARK1 | 3.25625365 |
5 | MAP3K4 | 2.84312431 |
6 | MINK1 | 2.59529298 |
7 | NTRK2 | 2.32673367 |
8 | MAP2K7 | 2.24964780 |
9 | DAPK2 | 2.19245786 |
10 | PAK6 | 2.19158427 |
11 | RIPK4 | 2.18750978 |
12 | NTRK1 | 2.17877794 |
13 | KSR2 | 2.10112805 |
14 | PNCK | 1.90904354 |
15 | PRKD3 | 1.81892648 |
16 | TNIK | 1.81382999 |
17 | MAP2K4 | 1.79036507 |
18 | CAMKK1 | 1.70921530 |
19 | MAP3K12 | 1.67605008 |
20 | SIK2 | 1.64726198 |
21 | CDK5 | 1.60332934 |
22 | KSR1 | 1.50218530 |
23 | CASK | 1.48880435 |
24 | GRK5 | 1.36952503 |
25 | MAPK13 | 1.33540683 |
26 | FES | 1.31580281 |
27 | ARAF | 1.27533601 |
28 | STK38 | 1.27145015 |
29 | TYRO3 | 1.24781237 |
30 | MAP3K13 | 1.24365035 |
31 | PLK2 | 1.23199358 |
32 | UHMK1 | 1.21914197 |
33 | CDK19 | 1.21313723 |
34 | DAPK1 | 1.19576774 |
35 | PRKCG | 1.17249554 |
36 | PHKG2 | 1.15945574 |
37 | PHKG1 | 1.15945574 |
38 | PRPF4B | 1.14007158 |
39 | MAPK12 | 1.08455147 |
40 | MAP3K2 | 1.08283192 |
41 | LATS2 | 1.00337177 |
42 | CAMKK2 | 0.97308085 |
43 | * CAMK2A | 0.96116092 |
44 | STK11 | 0.94720920 |
45 | CAMK2B | 0.94434260 |
46 | CDK15 | 0.92786606 |
47 | CDK18 | 0.91867108 |
48 | CDK14 | 0.90619482 |
49 | RET | 0.89653703 |
50 | CAMK1 | 0.89304827 |
51 | SGK223 | 0.88819293 |
52 | SGK494 | 0.88819293 |
53 | OXSR1 | 0.88491490 |
54 | CSNK1G2 | 0.84739340 |
55 | PRKCH | 0.83899847 |
56 | PAK3 | 0.81660628 |
57 | CDK11A | 0.81601539 |
58 | TAOK1 | 0.79978712 |
59 | MARK2 | 0.79647720 |
60 | ALK | 0.77194115 |
61 | RAF1 | 0.77150603 |
62 | PINK1 | 0.75090793 |
63 | WNK1 | 0.74114335 |
64 | TNK2 | 0.73565877 |
65 | DYRK1A | 0.73218376 |
66 | SGK1 | 0.71695094 |
67 | LMTK2 | 0.71364436 |
68 | BMPR2 | 0.71149963 |
69 | PTK2B | 0.70732409 |
70 | FGR | 0.65528495 |
71 | CAMK1G | 0.64986281 |
72 | SGK2 | 0.64099039 |
73 | STK39 | 0.61965166 |
74 | PDPK1 | 0.60217158 |
75 | PDK1 | 0.60076242 |
76 | CAMK2D | 0.58525555 |
77 | SGK3 | 0.58151060 |
78 | NEK6 | 0.55241764 |
79 | CAMK2G | 0.55128597 |
80 | FYN | 0.53431776 |
81 | PRKCZ | 0.53408822 |
82 | MAPKAPK5 | 0.53288249 |
83 | MAP3K1 | 0.53195526 |
84 | RPS6KA3 | 0.50557099 |
85 | BRSK1 | 0.49995292 |
86 | ERBB2 | 0.49644514 |
87 | PRKCE | 0.49439020 |
88 | CDC42BPA | 0.48518955 |
89 | PKN1 | 0.47049265 |
90 | MAP3K7 | 0.45716368 |
91 | ROCK2 | 0.45351691 |
92 | RIPK1 | 0.44152897 |
93 | MAP3K11 | 0.41832881 |
94 | * MAPK10 | 0.40935582 |
95 | FGFR2 | 0.39984142 |
96 | BRAF | 0.38208233 |
97 | PDGFRA | 0.37509240 |
98 | CAMK1D | 0.37319407 |
99 | ROCK1 | 0.37214308 |
100 | FER | 0.36611752 |
101 | SCYL2 | 0.36553495 |
102 | CSNK1G3 | 0.36110066 |
103 | MAP2K6 | 0.35949878 |
104 | MAPK8 | 0.35078831 |
105 | CAMK4 | 0.34665631 |
106 | MAPK7 | 0.33879574 |
107 | PRKCB | 0.32741564 |
108 | JAK2 | 0.32486411 |
109 | DAPK3 | 0.32372141 |
110 | DMPK | 0.31556072 |
111 | MUSK | 0.31021841 |
112 | NME1 | 0.31012464 |
113 | MAP2K1 | 0.30593843 |
114 | TRIB3 | 0.29598684 |
115 | BMX | 0.29366549 |
116 | MAPK4 | 0.28493735 |
117 | PRKG1 | 0.28475025 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.87875378 |
2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.03124057 |
3 | * GABAergic synapse_Homo sapiens_hsa04727 | 2.71716567 |
4 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.70711767 |
5 | Long-term potentiation_Homo sapiens_hsa04720 | 2.67845451 |
6 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.67580750 |
7 | Circadian entrainment_Homo sapiens_hsa04713 | 2.66144127 |
8 | Olfactory transduction_Homo sapiens_hsa04740 | 2.65136670 |
9 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.47168709 |
10 | * Morphine addiction_Homo sapiens_hsa05032 | 2.46733185 |
11 | Salivary secretion_Homo sapiens_hsa04970 | 2.23842719 |
12 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.23733193 |
13 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.19014519 |
14 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.94864388 |
15 | Insulin secretion_Homo sapiens_hsa04911 | 1.91715238 |
16 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.89198641 |
17 | Cocaine addiction_Homo sapiens_hsa05030 | 1.84596676 |
18 | Long-term depression_Homo sapiens_hsa04730 | 1.83243553 |
19 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.78272751 |
20 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.74672094 |
21 | * Taste transduction_Homo sapiens_hsa04742 | 1.72436500 |
22 | Renin secretion_Homo sapiens_hsa04924 | 1.72373448 |
23 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.67088509 |
24 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.63050600 |
25 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.62807149 |
26 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.46647584 |
27 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.45842418 |
28 | Gap junction_Homo sapiens_hsa04540 | 1.40511699 |
29 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.33727885 |
30 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.31909513 |
31 | * cAMP signaling pathway_Homo sapiens_hsa04024 | 1.26616317 |
32 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.25563246 |
33 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.25369175 |
34 | Axon guidance_Homo sapiens_hsa04360 | 1.20535014 |
35 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.20453467 |
36 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.14749238 |
37 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.11809516 |
38 | * Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.09978138 |
39 | * Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.07938873 |
40 | Melanogenesis_Homo sapiens_hsa04916 | 1.06509195 |
41 | Glioma_Homo sapiens_hsa05214 | 1.04795637 |
42 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.01675226 |
43 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.00829785 |
44 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.00310159 |
45 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.99439617 |
46 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.97167812 |
47 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.95753967 |
48 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.93897298 |
49 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.93057278 |
50 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.86861322 |
51 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.83792106 |
52 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.81952851 |
53 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.80078055 |
54 | Phototransduction_Homo sapiens_hsa04744 | 0.79723174 |
55 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.76725819 |
56 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.75448485 |
57 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.75413379 |
58 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.73246702 |
59 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.72043876 |
60 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.71694213 |
61 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.68263996 |
62 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.65121490 |
63 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.62629071 |
64 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.62366330 |
65 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.62257986 |
66 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.59071913 |
67 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.58994215 |
68 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.58549297 |
69 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.58159386 |
70 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.57837323 |
71 | Bile secretion_Homo sapiens_hsa04976 | 0.55467309 |
72 | Alcoholism_Homo sapiens_hsa05034 | 0.55323498 |
73 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.54023060 |
74 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.50812082 |
75 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.50809434 |
76 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.50167339 |
77 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.48813902 |
78 | Endocytosis_Homo sapiens_hsa04144 | 0.47161022 |
79 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.45251400 |
80 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.45249962 |
81 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.44396685 |
82 | Prion diseases_Homo sapiens_hsa05020 | 0.42911370 |
83 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.41984300 |
84 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.41038974 |
85 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.40907190 |
86 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.39907267 |
87 | Alzheimers disease_Homo sapiens_hsa05010 | 0.38292706 |
88 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.37973612 |
89 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.37532448 |
90 | Endometrial cancer_Homo sapiens_hsa05213 | 0.37118095 |
91 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.37053269 |
92 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.36711235 |
93 | Circadian rhythm_Homo sapiens_hsa04710 | 0.35988023 |
94 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.35746421 |
95 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.34935372 |
96 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.33457176 |
97 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.33399050 |
98 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.32410282 |
99 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.31579768 |
100 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.30540732 |
101 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.28293371 |
102 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.28290472 |
103 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.28275358 |
104 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.28205411 |
105 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.27907949 |
106 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.27830367 |
107 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.26744077 |
108 | Tight junction_Homo sapiens_hsa04530 | 0.26547842 |
109 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.26470480 |
110 | Platelet activation_Homo sapiens_hsa04611 | 0.24693437 |